Analyst Ratings For Gilead Sciences (NASDAQ:GILD)
Today, Maxim Group reiterated its Hold rating on Gilead Sciences (NASDAQ:GILD).
There are 11 hold ratings, 15 buy ratings, 1 strong buy rating on the stock.
The current consensus rating on Gilead Sciences (NASDAQ:GILD) is Buy (Score: 2.63) with a consensus target price of $80.10 per share, a potential 6.85% upside.
Some recent analyst ratings include
- 7/27/2017-Maxim Group Reiterated Rating of Hold.
- 7/26/2017-Redburn Partners initiated coverage with a Buy rating.
- 7/25/2017-Robert W. Baird Reiterated Rating of Outperform.
- 7/25/2017-Leerink Swann Reiterated Rating of Hold.
- 7/21/2017-BMO Capital Markets Reiterated Rating of Hold.
- 7/11/2017-Morgan Stanley Reiterated Rating of Equal Weight.
Dividend information for Gilead Sciences (NASDAQ:GILD)
Gilead Sciences (NASDAQ:GILD) pays an annual dividend of Community Ranking: with a yield of 2.77%.
Dividend History for Gilead Sciences (NASDAQ:GILD)
- On 7/26/2017 Gilead Sciences announced a quarterly dividend of $0.52 2.78% with an ex dividend date of 9/14/2017 which will be payable on 9/28/2017.
- On 5/2/2017 Gilead Sciences announced a quarterly dividend of $0.52 3.09% with an ex dividend date of 6/14/2017 which will be payable on 6/29/2017.
- On 2/7/2017 Gilead Sciences announced a quarterly dividend of $0.52 3.11% with an ex dividend date of 3/14/2017 which will be payable on 3/30/2017.
- On 11/1/2016 Gilead Sciences announced a quarterly dividend of $0.47 2.59% with an ex dividend date of 12/13/2016 which will be payable on 12/29/2016.
- On 7/25/2016 Gilead Sciences announced a quarterly dividend of $0.47 2.32% with an ex dividend date of 9/14/2016 which will be payable on 9/29/2016.
- On 4/28/2016 Gilead Sciences announced a quarterly dividend of $0.47 2.13% with an ex dividend date of 6/14/2016 which will be payable on 6/29/2016.
- On 2/2/2016 Gilead Sciences announced a quarterly dividend of $0.43 1.99% with an ex dividend date of 3/14/2016 which will be payable on 3/30/2016.
Recent Insider Trading Activity For Gilead Sciences (NASDAQ:GILD)
Gilead Sciences (NASDAQ:GILD) has insider ownership of 1.30% and institutional ownership of 74.05%.
- On 7/21/2017 Gregg H Alton, EVP, sold 40,000 with an average share price of $74.00 per share and the total transaction amounting to $2,960,000.00. View SEC Filing
- On 7/3/2017 Gregg H Alton, EVP, sold 5,000 with an average share price of $71.06 per share and the total transaction amounting to $355,300.00. View SEC Filing
- On 7/3/2017 John C Martin, Insider, sold 73,333 with an average share price of $71.00 per share and the total transaction amounting to $5,206,643.00. View SEC Filing
- On 5/9/2017 John Francis Cogan, Director, sold 9,943 with an average share price of $67.25 per share and the total transaction amounting to $668,666.75. View SEC Filing
- On 4/3/2017 John C Martin, Insider, sold 73,333 with an average share price of $67.18 per share and the total transaction amounting to $4,926,510.94. View SEC Filing
- On 3/30/2017 Gregg H Alton, EVP, sold 5,000 with an average share price of $67.48 per share and the total transaction amounting to $337,400.00. View SEC Filing
- On 1/3/2017 John C Martin, Insider, sold 73,337 with an average share price of $73.59 per share and the total transaction amounting to $5,396,869.83. View SEC Filing
Recent Trading Activity for Gilead Sciences (NASDAQ:GILD)
Shares of Gilead Sciences closed the previous trading session at 74.96 up +0.77 1.04% with 10,695,344 shares trading hands.